Association of Cancer Care Centers (ACCC) Market Research Report

Background

Overview

The Association of Cancer Care Centers (ACCC), formerly known as the Association of Community Cancer Centers, is a leading education and advocacy organization for the cancer care community. Established in 1974, ACCC has grown into a robust network comprising over 45,000 multidisciplinary professionals from more than 1,700 organizations nationwide. It is estimated that 65% of the nation's cancer patients receive treatment from an ACCC member.

Mission and Vision

ACCC's mission is to support its diverse community of multidisciplinary professionals through education and advocacy efforts that identify practical solutions for the complex changes and challenges involved in delivering quality cancer care. The organization's vision is to be the leading resource and advocate for cancer care providers, ensuring access to comprehensive, high-quality, and patient-centered care across the United States.

Primary Area of Focus

ACCC focuses on enhancing the quality of cancer care by providing resources, education, and advocacy support to oncology professionals. This includes addressing operational and management challenges, reimbursement issues, policy and regulatory changes, and integrating new technologies and therapies into cancer care practices.

Industry Significance

As a prominent organization in the oncology sector, ACCC plays a pivotal role in shaping cancer care delivery. Its extensive network and comprehensive resources make it a key player in promoting quality care, influencing policy, and driving innovation within the cancer care community.

Key Strategic Focus

Core Objectives

Education and Advocacy: Providing continuous education and advocacy to oncology professionals to navigate the evolving landscape of cancer care.

Operational Support: Offering resources to address operational challenges, including reimbursement issues and policy changes.

Innovation Integration: Facilitating the integration of new technologies and therapies into cancer care practices.

Specific Areas of Specialization

Multidisciplinary Collaboration: Fostering collaboration among various oncology disciplines to enhance patient care.

Policy and Regulatory Advocacy: Engaging in advocacy efforts to influence healthcare policies and regulations affecting cancer care.

Quality Improvement Projects: Designing and implementing projects aimed at improving the quality and efficiency of cancer care delivery.

Key Technologies Utilized

ACCC collaborates with technology partners to enhance cancer care delivery. For instance, in May 2024, ACCC partnered with Flatiron Health to improve study data capture in clinical trials, aiming to make clinical trials more accessible and efficient for community practices.

Primary Markets or Conditions Targeted

ACCC serves a broad spectrum of oncology professionals and cancer care centers across the United States, focusing on various cancer types and treatment modalities. Its resources and initiatives are designed to support the entire continuum of cancer care, from prevention and early detection to treatment and survivorship.

Financials and Funding

Funding History

As a non-profit organization, ACCC's funding primarily comes from membership dues, corporate partnerships, and grants. While specific financial details are not publicly disclosed, ACCC's substantial network and partnerships indicate a robust financial foundation.

Total Funds Raised

Specific figures regarding total funds raised are not publicly available.

Recent Funding Rounds

ACCC's recent initiatives, such as the partnership with Flatiron Health, suggest ongoing efforts to secure funding and resources to support its programs and services.

Notable Investors

ACCC collaborates with various stakeholders, including healthcare providers, technology companies, and policy organizations, to advance its mission. Notably, the partnership with Flatiron Health in 2024 highlights the organization's engagement with leading health technology companies.

Intended Utilization of Capital

Funds are utilized to support educational programs, advocacy efforts, quality improvement projects, and the integration of innovative technologies into cancer care practices.

Pipeline Development

As a professional association, ACCC does not develop clinical products or therapies. Instead, it focuses on supporting its members through education, advocacy, and resources to enhance cancer care delivery.

Technological Platform and Innovation

Proprietary Technologies

ACCC does not develop proprietary technologies but collaborates with technology partners to enhance cancer care delivery.

Significant Scientific Methods

ACCC employs evidence-based practices and collaborates with research organizations to disseminate the latest scientific findings to its members.

AI-Driven Capabilities

ACCC's partnership with Flatiron Health includes access to Flatiron Clinical Pipe™, an electronic health record (EHR) to electronic data capture (EDC) connector that improves efficiency and reduces time and effort in clinical study data capture.

Leadership Team

Key Executive Profiles

Olelekan Ajayi, PharmD, MBA: ACCC President.

Nadine Barrett, PhD, MA, MS: ACCC President-Elect.

Professional Backgrounds

Specific professional backgrounds of the leadership team are not detailed in the available sources.

Key Contributions or Roles within the Company

Both leaders have been instrumental in guiding ACCC through its 50th anniversary and the rebranding to reflect the dynamic future of cancer care.

Leadership Changes

Recent Significant Changes or Appointments

In February 2024, ACCC announced its 50th anniversary and rebranding to the Association of Cancer Care Centers, reflecting its evolving mission and vision.

Competitor Profile

Market Insights and Dynamics

The oncology care sector is characterized by a growing emphasis on multidisciplinary collaboration, patient-centered care, and the integration of innovative technologies. Organizations like ACCC play a crucial role in supporting these trends through education, advocacy, and resource provision.

Competitor Analysis

ACCC's primary competitors include other professional associations and organizations that support oncology professionals and cancer care centers, such as the American Association for Cancer Research (AACR) and the Community Oncology Alliance (COA). Each organization offers unique resources and services tailored to different aspects of cancer care.

Strategic Collaborations and Partnerships

Significant Collaborations

ACCC's partnership with Flatiron Health in 2024 is a notable collaboration aimed at improving study data capture in clinical trials, thereby enhancing access to clinical trials in community settings.

Strategic Opportunities and Future Directions

ACCC continues to explore partnerships and initiatives that align with its mission to support the evolving needs of the cancer care community, focusing on education, advocacy, and the integration of innovative solutions to improve patient outcomes.